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Background: The associations between prenatal exposure 
to endocrine disruptive chemicals (EDCs) and fetal growth are 
inconsistent, and few studies have considered small-for-ges-
tational-age (SGA) birth as an outcome. Our current study of 
Scandinavian parous women aimed to address these inconsis-
tencies and gaps in the literature.
Methods: This case–cohort study included 424 mother–
child pairs who participated in a prospective, multi-center 
study of parous women in Norway (Trondheim and Bergen) 
and Sweden (Uppsala). We used linear and logistic regression 
with 95% confidence intervals (CIs) to analyze the associa-
tions between two perfluoroalkyl substances (PFASs) and five 
organochlorines (OCs) from early second trimester and indices 
of fetal growth.
results: Among Swedish women, prenatal exposure to per-
fluorooctanoate (PFOA), polychlorinated biphenyl (PCB) 153 
and hexachlorobenzene (HCB) were associated with higher 
odds for SGA birth. We found stronger associations among 
Swedish male offspring. In the Norwegian cohort, we found 
no significant associations between EDC exposure and indices 
of fetal growth.
conclusions: Some populations may be more vulnerable 
to EDCs, possibly due to differences in exposure levels, expo-
sure sources and/or modifiable lifestyle factors. Male offspring 
may be more vulnerable to endocrine disruption.
Fetal growth restriction (FGR) is defined as a pathologic inhibition of intrauterine fetal growth and failure to achieve 
the fetus’ growth potential. FGR is associated with perinatal 
mortality and morbidity. Small-for-gestational-age (SGA) is a 
proxy for FGR and defined as birth weight below the 10th per-
centile for gestational age, sex, and parity (1).
Perfluoroalkyl substances (PFASs) and organochlorines 
(OCs) are persistent, bio-accumulative chemicals that have 
been detected in maternal blood during pregnancy and in 
cord blood at delivery. PFASs and OCs may act as endocrine 
disrupting chemicals (EDCs), and in utero exposure to EDCs 
may have consequential developmental effects on the fetus 
(2). A United Nations Environment Program/World Health 
Organization (UNEP/WHO) report from 2012 identi-
fies human exposure to EDCs as an emerging challenge (3). 
Increased knowledge is required to ensure better protection 
for the most vulnerable members of society. Pregnant moth-
ers and children are particularly vulnerable to developmental 
exposures like EDCs, and fetal programming may increase 
susceptibility to diseases later in life (3).
The associations between EDCs and indices of fetal growth 
have been studied in different populations, although results are 
inconsistent (4,5). Diet is considered an important exposure 
route for PFASs and OCs even in periods with simultaneous 
direct exposure from production and emission of chemicals 
(6). In Scandinavian populations, consumption of seafood 
have been associated with high PFAS and OC serum lev-
els (7,8). The Baltic Sea, which is situated on the East coast 
of Sweden, has been vastly contaminated with OCs (9), and 
a study of births in Sweden from 1973–1991 found associa-
tions between high maternal intake of fish from the Baltic Sea 
and restricted fetal growth (10). However, most other stud-
ies report positive associations between higher maternal fish 
intake and better fetal growth (11). Dietary intake of fish from 
different water sources may result in population-specific EDC 
exposures. Taken together, source-specific fish intake may 
confound associations between EDCs and fetal growth.
Most observational studies have been underpowered to 
detect significant associations between EDCs and SGA birth, 
or only included birth weight as an outcome. A most recent 
systematic review of prenatal serum levels of PFASs and human 
fetal growth published in 2015, recommended that future EDC 
exposure studies should focus on SGA birth as an outcome of 
interest (4).
In the current study, we used a case–cohort design to study 
the association between maternal serum levels of PFASs and 
OCs and indices of fetal growth including birth weight, birth 
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length, head circumference, and SGA birth in Scandinavian 
women from Norway and Sweden. We also explored possible 
effect modification by country and offspring sex.
RESULTS
Maternal and Offspring Baseline Characteristics
Overall, Swedish women had, on average, higher prepreg-
nancy BMI (22 vs. 21 kg/m2) compared to Norwegian women. 
A greater proportion of Swedish women were nonsmok-
ers at the time of conception compared to their Norwegian 
peers (67 vs. 47% nonsmokers) (Table 1). The total cohort of 
Swedish mothers compared to Norwegian mothers did not 
differ significantly in other baseline characteristics (maternal 
age, height, education, parity, and interpregnancy interval). 
Swedish offspring were on average longer at birth compared 
to Norwegian offspring, but did not differ significantly in 
other characteristics (birth weight, head circumference, and 
gestational age).
Swedish women who gave birth to SGA offspring (SGA 
mothers) were on average shorter, had lower prepregnancy 
BMI, fewer years of education, and lower parity compared to 
Swedish women with non-SGA births (non-SGA mothers). A 
higher proportion of Swedish SGA mothers reported smok-
ing at conception compared to Swedish non-SGA mothers (60 
vs. 21% smokers). We observed a similar pattern in baseline 
characteristics when Norwegian SGA and non-SGA mothers 
were compared. Norwegian SGA mothers were also signifi-
cantly younger than Norwegian non-SGA mothers (28 vs. 29 
y of age). Swedish SGA offspring had, on average, lower birth 
weight, shorter birth length and smaller head circumference 
compared to Swedish non-SGA offspring. Norwegian SGA off-
spring had in addition significantly lower gestational age com-
pared to the Norwegian non-SGA offspring.
PFAS and OC Levels
Overall, Swedish mothers had significantly higher median 
serum levels of PFOA (2.33 vs. 1.62 ng/ml), perfluoroctane sul-
fonate (PFOS) (16.4 vs. 9.74 ng/ml), PCB 153 (117 vs. 80.1 ng/g 
lipid), and β-HCH (25.0 vs. 21.2 ng/g lipid) compared to the 
total Norwegian cohort (Table 2, Figure 1). Swedish moth-
ers had significantly lower median serum levels of t-NC (6.28 
vs. 6.74 ng/g lipid) compared to Norwegian mothers (Table 2, 
Figure 1).
Median levels of PFOA and PCB 153 were significantly 
higher among Swedish SGA mothers compared to Swedish 
non-SGA mothers (Figure 1). Differences in levels of other 
EDCs (PFOS, p,p’-DDE, HCB, β-HCH and t-NC) were not sta-
tistically significant when Swedish SGA mothers and Swedish 
non-SGA mothers were compared (Figure 1).
We observed no significant differences in PFAS or OC levels 
between Norwegian SGA mothers and Norwegian non-SGA 
mothers.
Overall, there were medium to high correlations within the 
PFASs (ρ = 0.56–0.73) and within the OCs (ρ = 0.29–0.70) 
(Supplementary Figure S1 online). However, the PFASs 
were not highly correlated with the OCs (ρ = −0.01–0.22) 
(Supplementary Figure S1 online). The same pattern was 
observed in both Norwegian and Swedish cohorts.
Associations Between PFAS and OC Levels and Indices of Fetal 
Growth
In the pooled analyses including data from both Norway and 
Sweden, we found no significant associations between EDCs 
and indices of fetal growth after adjustment for important 
covariates (Supplementary Table S1 online).
Table 3 shows associations between serum levels of PFASs 
and OCs and indices of fetal growth stratified by country of 
residence. In adjusted linear models for the Swedish cohort, 
birth weight decreased significantly by −359 g (95% CI: −596, 
−122) and −292 g (95% CI: −500, −84) per ln-unit increase 
in PFOA and PFOS, respectively. Birth length was also nega-
tively associated with increasing levels of PFOA and PFOS. For 
each ln-unit increase in HCB levels, a significant decrease in 
head circumference (β = −1.0 cm (95% CI: −1.7, −0.2)) was 
observed after adjustment.
In multivariate logistic regression models for the Swedish 
cohort, we observed a significant increase in adjusted odds 
for SGA birth per ln-unit increase in PFOA (aOR = 5.25 (95% 
CI: 1.68–16.4)), PCB 153 (aOR = 5.59 (95% CI: 1.05–29.9)) 
and HCB (aOR = 5.62 (95% CI: 1.26–25.1)). We also observed 
increased aOR for SGA birth per ln-unit increase in PFOS 
(aOR = 2.51 (95% CI: 0.93–6.77)), although nonsignificant. 
Among Swedish women, there were no significant associations 
between levels of PFASs or OCs and gestational age (Table 3). 
Among Norwegian women, we observed no statistically signif-
icant associations between PFASs or OCs and indices of fetal 
growth (Table 3).
In the Swedish cohort, the P value for interaction between 
PFOA and infant sex was 0.046 in multivariate linear regres-
sion models with birth weight as an outcome. No other inter-
action terms between EDCs and infant sex were statistically 
significant (P < 0.10) (data not shown). In Swedish male off-
spring, we observed a significant decrease in birth weight (β = 
−526 g; 95% CI: −828, −222) and birth length (β = −1.6 cm; 
95% CI: −2.9, −0.4) for each ln-unit increase in PFOA (Table 4 
and Figure 2). We also observed a significant increase in 
adjusted odds for SGA birth (aOR = 6.55; 95% CI: 1.14–37.5) 
among male Swedish offspring (Table 4 and Figure 2). No sta-
tistically significant associations between PFOA and indices of 
fetal growth were observed among Swedish female offspring. 
We found no significant interaction terms between PFASs 
or OCs and offspring sex in the Norwegian cohort (data not 
shown).
DISCUSSION
In this case–cohort study of 424 Scandinavian parous women, 
we observed increased odds of SGA birth for each ln-unit 
increase in PFOA, PCB 153 and HCB, among Swedish but 
not Norwegian mothers. Increasing levels of PFOA, PFOS 
and HCB were negatively associated with other indices of 
fetal growth including birth weight, birth length and head 
circumference among the Swedish mothers. The associations 
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between PFOA and SGA birth, birth weight, birth height and 
head circumference were stronger among male offspring in 
the Swedish cohort. We found no statistically significant asso-
ciations between EDCs and indices of fetal growth among 
Norwegian women in this study population.
Birth weight, adjusted for gestational age at birth, is often 
used as a proxy for fetal growth in observational stud-
ies. However, adjusting for gestational age, which acts like a 
mediator in the association between birth weight and health 
outcomes, may introduce bias (12). SGA birth is a better 
marker for fetal growth restriction because it identifies babies 
with low birth weight accounting for the gestational age at 
birth. Only four studies have assessed associations between 
PFASs and SGA birth (13–16) with conflicting results. One 
study found increased odds for SGA with higher PFOS (13), 
and none found statistically significant associations with 
table 1. Maternal and offspring baseline characteristics by country and SGA status
Norway (Trondheim: N = 137, Bergen: N = 128) Sweden (Uppsala: N = 159)
Non-SGA (N = 174) SGA (N = 91) Total (N = 265) Non-SGA (N = 107) SGA (N = 52) Total (N = 159)
Mean (95% CI)  
or n (%)
Mean (95% CI)  
or n (%)
Mean (95% CI)  
or n (%)
Mean (95% CI)  
or n (%)
Mean (95% CI)  
or n (%)
Mean (95% CI)  
or n (%)
Maternal characteristics
High-risk group 0 (0) 74 (81)* 74 (28) 0 (0) 43 (83)* 43 (27)
10% random sample 174 (100) 17 (19)* 191 (72) 107 (100) 9 (17)* 115 (73)
Maternal age 29.3 (28.6–29.9) 27.9 (27.0–28.7)* 28.8 (28.3–29.3) 29.5 (28.7–30.3) 28.9 (27.5–30.4) 29.3 (28.6–30.0)
Maternal height 167.0 (166.1–167.9) 164.3 (163.2–165.4)* 166.1 (165.3–166.8) 166.6 (165.5–167.7) 164.2 (162.7–165.7)* 165.8 (164.9–166.7)
Maternal prepregnancy 
BMI
21.6 (21.2–22.0) 20.2 (19.7–20.7)* 21.1 20.8-21.4) 22.6 (22.1–23.1) 20.9 (20.2–21.6)* 22.1 (21.6–22.5)*
Education (years)
  9 or less 20 (12) 19 (21)* 39 (15) 16 (15) 15 (29)* 31 (20)
  10–12 93 (53) 54 (60) 147 (56) 46 (44) 17 (33) 63 (41)
  13 or more 61 (35) 17 (19)* 77 (29) 42 (40) 19 (37) 60 (39)
Smoking at conception (number of cigarettes)
  0 103 (59) 20 (22)* 123 (47) 85 (79) 21 (40)* 106 (67)*
  1–9 21 (12) 14 (16) 35 (13) 4 (3.7) 3 (5.8) 7 (4.4)
  10 or more 50 (29) 56 (62)* 106 (40) 18 (17) 28 (54)* 46 (29)
Parity
  1 122 (70) 65 (71) 186 (71) 66 (62) 39 (75)* 104 (66)
  2 52 (30) 26 (29) 78 (29) 41 (38) 13 (25) 54 (34)
Interpregnancy interval (months)
  18 or less 43 (25) 14 (15) 57 (22) 26 (24) 20 (39)* 46 (29)
  19–60 98 (56) 56 (62) 154 (58) 58 (54) 21 (40) 79 (50)
  61 or more 33 (19) 21 (23) 54 (20) 23 (22) 11 (21) 34 (21)
Offspring characteristics
Gender
  Male 87 (50) 47 (52)* 133 (50) 52 (49) 29 (56)* 81 (51)
  Female 87 (50) 44 (48) 131 (50) 55 (51) 23 (44) 77 (49)
Weight (g) 3661 (3590–3732) 2882 (2815–2949)* 3402 (3335–3469) 3790 (3680–3900) 2891 (2820–2963)* 3503 (3403–3601)
Length (cm) 50.8 (50.5–51.1) 48.3 (47.9–48.8)* 50.0 (49.8–50.3) 51.4 (50.9–51.9) 48.4 (48.0–48.8)* 50.5 (50.1–50.8)*
Head circumference 
(cm)
35.4 (35.2–35.5) 34.0 (33.7–34.2)* 34.9 (34.7–35.1) 35.5 (35.2–35.8) 33.7 (33.4–33.9)* 34.9 (34.7–35.1)
Gestational age 40.0 (39.8–40.2) 39.7 (39.4–40.0) 39.9 (39.8–40.1) 40.2 (40.0–40.6) 39.5 (39.1–39.9)* 40.1 (39.9–40.3)
*Total group: Significant difference between the total group in Norway vs. the total group in Sweden (P < 0.05) using Student t-test for normally distributed variables and  
Mann-Whitney U-test for categorical variables. SGA-group: Significant difference between SGA vs. non-SGA group within country strata (P < 0.05) using Student t-test for normally 
distributed variables and Mann-Whitney U-test for categorical variables.
SGA, small for gestational age.
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PFOA. In contrast, we observed increased odds for SGA birth 
with increasing levels of PFOA in our Swedish study popula-
tion. Our finding of increased odds for SGA birth with increas-
ing levels of PCB 153 in the Swedish cohort has not previously 
been reported, but is consistent with a recent meta-analysis 
that established an association between PCB 153 and birth 
weight (5). The increased odds for SGA birth with increasing 
levels of HCB among our Swedish women has not been estab-
lished in previous studies.
The possible biological mechanisms for the effects of PFASs 
and OCs on fetal growth are uncertain, but their endocrine-
disruptive properties may be involved. Normal development 
is highly dependent on thyroid and sex steroid hormones, and 
the prenatal period is a critical period for hormonal changes. 
Thyroid hormones are important for somatic growth and are 
involved in differentiation and functions of target tissues dur-
ing development (17). Prenatal estrogens are also important in 
promoting fetal growth (18). Both PFASs and OCs have been 
associated with lower levels of circulating thyroid hormones 
(19,20). Competitive binding to estrogenic receptors, disrup-
tion of enzymes or inhibition of the effects of endogenous 
estrogens are hypothesized actions of estrogenic and anties-
trogenic PCB congeners, and may lead to inhibition of fetal 
growth (21). Moreover, human in vitro studies have found that 
PFASs interfere with the estrogen and androgen receptor (22). 
Since sex steroids might be disrupted by PFASs and OCs, there 
could be different effects in male and female fetuses which may 
explain our findings of stronger negative associations between 
PFOA and indices of restricted fetal growth among male but 
not female offspring in the Swedish cohort. Our sex specific 
finding differs from a Japanese study from 2009 that showed 
stronger negative associations between PFOS and birth weight 
among girls (n = 428 mother–child pairs) (23). The biologi-
cal mechanisms for the sex difference in the toxicity for PFOA 
remains to be established, and it is possible that decreasing the 
sample size by stratifying our groups by sex reduced the preci-
sion of our results. Thus, further studies are warranted to elu-
cidate any sex-related differences in fetal growth indices based 
on in utero exposure to PFASs.
The conflicting estimates on fetal growth between the 
Norwegian and Swedish cohort may be explained by differ-
ences in exposure levels and heterogeneity in exposure routes. 
Seafood and particularly fatty fish have been associated with 
high PFAS and OC levels in Scandinavian populations (7,8). 
In our study, Norwegian women with fish consumption 
> 50 g/d in the second trimester had 20 and 19% higher PFOA 
and PFOS levels, respectively, compared to women who did 
not eat fish (Supplementary Table S2 online). However, other 
food items, like meat, may be more important in other pop-
ulations with less fish intake (24). Moreover, we cannot dis-
count the possibility of differences in dietary patterns between 
Scandinavian countries, which may partially account for our 
results. Since fish consumption is associated with both EDC 
levels and fetal growth, this may introduce bias in epidemio-
logical studies. A recent report from the Norwegian Scientific 
Committee for Food Safety concluded that overall, there is a 
beneficial effect of fish consumption on birth weight, because 
fatty acids and vitamins important for enhancing fetal growth 
outweigh potential negative effects from EDCs (11). However, 
it is important to note that this evaluation was based on evi-
dence from studies conducted when EDC levels were lower 
than the EDC levels found during our study period (1986–88). 
Our estimates in the Norwegian cohort did not substantially 
change when we adjusted for fish consumption (data not 
table 2. Wet-weight levels of PFASs, and wet-weight and lipid-adjusted levels of OCs in serum by country from the study population in the  
SGA-study, N = 424
Norway Sweden
LOD %>LODMedian (range) AM (SD) Median (range) AM (SD)
Wet-weight (ng/ml)
PFOA 1.62 (0.31–7.97) 1.83 (1.00) 2.33 (0.60–6.70) 2.42 (1.00) 0.03 100
PFOS 9.74 (0.95–59.6) 11.3 (7.02) 16.4 (2.28–55.2) 17.3 (7.45) 0.03 100
PCB 153 0.46 (0.17–1.30) 0.49 (0.18) 0.68 (0.25–1.40) 0.69 (0.21) 0.01 100
p,p’-DDE 1.20 (0.10–11.0) 1.65 (1.43) 1.30 (0.39–9.20) 1.62 (1.13) 0.09 100
HCB 0.10 (0.04–0.33) 0.11 (0.04) 0.10 (0.04–0.38) 0.11 (0.04) 0.04 100
t-NC 0.04 (0.01–0.14) 0.04 (0.02) 0.04 (0.01–0.10) 0.04 (0.02) 0.01 100
β-HCH 0.12 (<LOD-0.39) 0.13 (0.06) 0.13 (<LOD-0.76) 0.15 (0.08) 0.01 99
Lipid-adjusted (ng/g lipids)
PCB 153 80.1 (31.0–212) 84.4 (28.4) 117 (45.4–212) 121 (32.8) – –
p,p’-DDE 209 (16.7–1791) 285 (238) 244 (71.2–1223) 284 (175) – –
HCB 17.2 (7.1–48.2) 18.4 (6.27) 18.3 (6.98–73.0) 19.2 (7.56) – –
t-NC 6.74 (2.37–25.2) 7.55 (3.52) 6.28 (1.82–17.3) 6.79 (2.79) – –
β-HCH 21.2 (<LOD-57.2) 22.7 (9.07) 25.0 (<LOD-134) 26.5 (13.5) – –
AM, arithmetic mean; HCB, hexachlorobenzene; LOD, limit of detection; %>LOD, percentage of samples over limit of detection. Levels below LOD were set to LOD/√2; PCB, 
polychlorinated biphenyl; PFOA, perfluorooctanoate; PFOS, perfluoroctane sulfonate.
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shown). Seasonal or daily variations in dietary intake of fish 
may introduce differential misclassification bias when using 
3 d dietary intake as a measure of the overall consumption pat-
tern, and we may not be able to capture the “real” fish eaters by 
this approach. We did not have information on fish consump-
tion in the Swedish cohort.
In addition to different dietary patterns between populations 
and temporal trends of EDCs, there might be differences in con-
tamination levels between fish sources. Studies have shown high 
OC contamination of the fish in the Baltic Sea on the East Coast 
of Sweden (9). Another study (1973–1991) that compared fish-
ermen’s pregnant wives from the East and West coast of Sweden, 
found that higher fish consumption from the East Coast resulted 
in higher maternal serum levels of PCB 153, which again resulted 
in increased risk of having an infant with low birth weight (25).
Smoking is often closely associated with socio-economic, 
dietary and lifestyle variables. In the Swedish cohort, 
smokers had 20% higher PFOA levels compared to non-
smokers (Supplementary Table S2 online). Whereas, in the 
Norwegian cohort, smokers had 19% lower PFOS levels com-
pared to nonsmokers. The fact that PFASs were higher among 
smokers in Sweden, but lower among smokers in Norway, 
speaks against a potential direct biologic effect of smoking 
on PFAS levels. In addition, we found no evidence of stron-
ger associations between PFASs and fetal growth among 
the smokers compared to the non-smokers in Norway or 
Sweden, respectively. Taken together, this suggests that there 
might be differences in socio-economic status, lifestyle, and 
dietary variables between the women with high PFAS levels 
in Norway and Sweden, respectively, which will further con-
found the analyses. Problems with individual and local differ-
ences in EDC levels will be greater during time periods with 
continued use of contaminants, and possible contamination 
of the drinking water with PFASs in Sweden (26) may account 
Figure 1. Levels of perfluoroalkyl substances (ng/ml) and organochlorines (ng/g lipids) analyzed in maternal serum in second trimester, stratified by 
country of residence and SGA status (a: PFOA, b: PCB 153, c: p,p’-DDE, d: HCB, e: PFOS, f: t-NC, g: β-HCH). White boxes: non-SGA mothers, light blue boxes: 
SGA-mothers. Boxes represent the 25th-75th percentiles, horizontal lines represents the median, whiskers indicate 1.5 times the length of the interquar-
tile range above and below the 75th and 25th percentiles, respectively, and outliers are represented as data points. *P ≤ 0.05, **P ≤ 0.01, and †P ≤ 0.001 
for comparisons of levels between countries and between SGAs and non-SGAs within each country. HCB, hexachlorobenzene; PCB, polychlorinated 
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for some differences between populations. Although we did 
not find evidence of effect modification by smoking in our 
study, the high proportion of smokers in our study population 
may introduce bias and thereby underestimate true effects of 
the contaminants. In addition, due to the strong associations 
between smoking and fetal growth, the true effects of EDCs 
could be overshadowed and hard to detect, even in adjusted 
analyses.
Assessing potential causal effects of multiple EDCs on 
health outcomes are complicated because of the complex 
correlation of exposures. Associations found in some stud-
ies may largely reflect correlated EDC exposures instead of a 
specific EDC under study. In our study, we found moderate 
or high correlations within the PFASs (ρ = 0.56–0.73) and 
within the OCs (ρ = 0.35–0.70) (Supplementary Figure S1 
online), but only weak correlations between the PFASs and 
OCs (ρ = −0.01–0.22). The lack of correlation between PFASs 
and OCs made it possible to distinguish between the inde-
pendent effects of PFASs and OCs. When assessing individ-
ual EDCs, we demonstrated positive associations between 
PFOA, PCB 153 and HCB and SGA birth (Table 3). However, 
the only association that remained statistically significant 
when including the other contaminants as covariates in final 
models was the association between PFOA and SGA birth 
(Supplementary Table S3 online). This further confirms that 
the association between PFOA and SGA birth is not explained 
by correlated exposures. The association between HCB and 
SGA birth was also significant when we adjusted for PFOA. 
Based on these analyses, it seems like both PFOA and HCB 
are independently associated with SGA birth. Accounting for 
correlations within and between different EDCs strength-
ens our findings by distinguishing between contaminants 
table 3. Beta coefficients (β) and odds ratios (ORs) with 95% confidence intervals (95% CI) for associations between PFAS and organochlorines 
and indices of fetal growth (Norway: N = 265, Sweden: N = 159)
Birth weight (g)a Birth length (cm)a Head circumferencea (cm) Gestational agea (weeks) SGAb
β (95% CI) P β (95% CI) P β (95% CI) P β (95% CI) P OR (95% CI) P
Norway
PFOA 37 (−99, 174) 0.590 −0.1 (−0.7, 0.4) 0.656 0.2 (−0.2, 0.5) 0.354 −0.2 (−0.6, 0.2) 0.431 0.66 (0.33–1.33) 0.246
PFOS 74 (−31, 178) 0.167 −0.0 (−0.4, 0.4) 0.987 0.2 (−0.1, 0.4) 0.189 −0.01 (−0.3, 0.3) 0.952 0.71 (0.42–1.20) 0.201
PCB 153 100 (−104, 304) 0.334 −0.1 (−1.0, 0.7) 0.772 0.2 (−0.3, 0.7) 0.507 0.1 (−0.5, 0.7) 0.693 0.70 (0.25–1.98) 0.502
p,p’-DDE 46 (−47, 139) 0.327 0.2 (−0.2, 0.6) 0.306 0.1 (−0.2, 0.3) 0.531 −0.04 (−0.3, 0.2) 0.747 0.73 (0.46–1.15) 0.174
HCB 61 (−132, 255) 0.534 0.1 (−0.7, 0.9) 0.792 0.1 (−0.4, 0.6) 0.626 −0.1 (−0.6, 0.5) 0.756 0.52 (0.20–1.34) 0.176
B-HCH −73 (−231, 86) 0.368 −0.5 (−1.1, 0.2) 0.152 −0.1 (−0.5, 0.3) 0.614 −0.1 (−0.6, 0.3) 0.592 0.76 (0.33–1.71) 0.500
t-NC 98 (−56, 253) 0.212 0.2 (−0.5, 0.8) 0.605 0.4 (−0.02, 0.8) 0.065 0.2 (−0.2, 0.7) 0.383 0.86 (0.40–1.84) 0.699
Sweden
PFOA −359 (−596, −122) 0.003 −1.3 (−2.3, −0.3) 0.010 −0.4 (−1.0, 0.1) 0.115 −0.3 (−0.9, 0.3) 0.318 5.25 (1.68–16.4) 0.004
PFOS −292 (−500, −84) 0.006 −1.2 (−2.1, −0.3) 0.007 −0.4 (−0.9, 0.04) 0.073 −0.4 (−0.9, 0.2) 0.201 2.51 (0.93–6.77) 0.068
PCB 153 −11 (−374, 352) 0.953 0.1 (−1.4, 1.6) 0.891 −0.2 (−1.1, 0.6) 0.558 0.6 (−0.4, 1.6) 0.222 5.59 (1.05–29.9) 0.044
p,p’-DDE 38 (−147, 223) 0.688 0.3 (−0.4, 1.1) 0.400 0.2 (−0.2, 0.7) 0.273 0.4 (−0.04, 0.9) 0.072 1.70 (0.75–3.85) 0.200
HCB −269 (−595, 57) 0.105 −1.0 (−2.4, 0.3) 0.134 −1.0 (−1.7, −0.2) 0.011 0.1 (−0.7, 1.0) 0.742 5.62 (1.26–25.1) 0.024
B-HCH −161 (−446, 125) 0.268 −0.4 (−1.6, 0.8) 0.537 −0.4 (−1.1, 0.2) 0.209 0.1 (−0.7, 0.8) 0.852 3.20 (0.84–12.1) 0.087
t-NC −92 (−379, 195) 0.529 −0.2 (−1.4, 1.0) 0.766 −0.4 (−1.1, 0.2) 0.213 0.3 (−0.5, 1.1) 0.452 2.04 (0.64–6.55) 0.229
aAdjusted for maternal age (years), height (cm), prepregnancy BMI (kg/m2), education (<9, 9–12, >12 y), parity (1 or 2), smoking status at conception (0, 1–9, >10 cig/d), interpregnancy 
interval (<18, 19–60, >60 mo) and offspring sex (male/female). bAdjusted for maternal age (years), height (cm), prepregnancy BMI (kg/m2), education (<9, 9–12, >12 y), smoking status 
at conception (0, 1–9, >10 cig/d), and interpregnancy interval (<18, 19–60, >60 mo).
HCB, hexachlorobenzene; PCB, polychlorinated biphenyl; PFOA, perfluorooctanoate; PFOS, perfluoroctane sulfonate.
table 4. Beta coefficients (β) and odds ratios (ORs) with 95% confidence intervals (95% CI) for associations between PFOA and indices of fetal 
growth in Sweden by offspring sex (N = 159)
Birth weight (g)a Birth length (cm)a Head circumferencea (cm) Gestational agea (weeks) SGAb
β (95% CI) P β (95% CI) P β (95% CI) P β (95% CI) P OR (95% CI) P
PFOA N
Boys 81 −526 (−828, −222) 0.001 −1.6 (−2.9, −0.4) 0.012 −0.6 (−1.3, 0.1) 0.103 −0.4 (−1.2, 0.5) 0.365 6.55 (1.14–37.45) 0.035
Girls 78 −156 (−541, 228) 0.419 −0.8 (−2.4, 0.8) 0.340 −0.1 (−1.0, 0.7) 0.728 −0.1 (−1.1, 0.9) 0.802 4.73 (0.79–28.3) 0.089
aAdjusted for maternal age (years), height (cm), prepregnancy BMI (kg/m2), education (<9, 9–12, >12 y), parity (1 or 2), smoking status at conception (0, 1–9, >10 cig/d), inter-pregnancy 
interval (<18, 19–60, >60 mo), and offspring sex (male/female). bAdjusted for maternal age (years), height (cm), prepregnancy BMI (kg/m2), education (<9, 9–12, >12 y), smoking status 
at conception (0, 1–9, >10 cig/d), and interpregnancy interval (<18, 19–60, >60 mo).
PFOA, perfluorooctanoate.
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that may have independent causal effects on restricted fetal 
growth.
This study has several strengths including a large, homo-
geneous population of mother–child pairs (n = 424). Ours 
is one of few studies to investigate a variety of PFAS and OC 
exposures. Since PFASs and OCs were not highly correlated, 
our results show an independent association between PFOA 
and fetal growth. The unique design of this case-cohort study 
accounts for a high proportion of SGA births as a marker for 
FGR, rather than birth weight alone. Therefore, this study has 
greater power to detect clinically relevant associations between 
EDCs and FGR using SGA birth as an outcome. We further 
tested the generalizability of our results by excluding the 
women from the high-risk group in all the linear and logistic 
models, and the associations in the Swedish cohort persisted 
(data not shown). The use of lipid-adjusted serum levels of OCs 
may be prone to bias in epidemiological studies (27). We there-
fore analyzed all linear and logistic models using wet weight 
values adjusted for total lipids as an independent variable with 
no considerable change in point estimates (data not shown). 
Maternal weight gain during pregnancy is suggested to be an 
important confounder in studies with lipophilic chemicals, 
but mainly in studies using serum from late pregnancy or cord 
blood (28). Since maternal weight gain also represents blood 
volume expansion, it may also be an important confounder 
in studies with PFASs, which largely are bound to albumin in 
the blood (4). Alcohol consumption may also be a confounder 
because it has been associated with higher levels of OCs (29). 
However, sensitivity analyses revealed that the estimates did 
not change when we included weight gain or alcohol con-
sumption as covariates in the analyses (Supplementary Tables 
S4 and S5 online).
This study also has some weaknesses. We have not cor-
rected for multiple comparisons, which increases the chance 
of a rare event and enables false-positive results (i.e., Type I 
error). Measures of renal filtration have been proposed to 
be important confounders in studies with PFASs and fetal 
growth (30). Unfortunately, we only had glomerular filtration 
Figure 2. Scatter plot with ln (PFOA (ng/ml)) values on the X-axis and adjusted values of birth weight (g) on the Y-axis, stratified by country and offspring 
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rate (GFR) for 88 women, and could not include GFR as a 
covariate in adjusted models due to problems with missing 
data. Primiparous women were not eligible for study inclu-
sion, which may contribute to some selection bias. However, 
excluding these women may largely reduce confounding due 
to parity because first time mothers have a higher risk of deliv-
ering small babies (31). At the same time, primiparous women 
may have higher serum EDC levels, because they lack previ-
ous excretion through placenta and breastmilk (2). Persistent 
and bio-accumulative chemicals with the same properties are 
highly correlated. Therefore, our point estimates may be sub-
ject to residual confounding due to some unmeasured chemi-
cals (e.g., lead) in our analyses.
Conclusion
We found higher odds for SGA birth with increasing serum 
levels of PFOA, PCB 153 and HCB, but only in the Swedish 
cohort. Both PFOA and HCB were associated with SGA birth 
after accounting for correlation between EDCs. We observed 
stronger associations between increasing levels of PFOA 
and SGA birth in male offspring from the Swedish cohort. 
Associations between EDCs and indices of fetal growth in the 
Norwegian cohort were null. Our results suggest that some 
populations may be more vulnerable to EDCs, possibly due to 
differences in EDC levels, exposure sources and/or potentially 
modifiable lifestyle factors. The study also suggests that male 




The project is approved by the Central Norway Regional Committee 
for Medical and Health Science Research Ethics (REK Midt 
2010/1449-5).
Study Population
Participants were from the US National Institute of Child Health and 
Human Development (NICHD) Scandinavian Successive Small-for-
Gestational Age (SGA) births study; a population-based prospective 
multicenter study conducted in Trondheim and Bergen (Norway) and 
Uppsala (Sweden). Participant recruitment occurred over a 27-mo 
period (1986–1988). The SGA births study was designed to study the 
etiology and consequences of intrauterine growth restriction (32). 
Since the study also examined the tendency for individual women to 
repeat an SGA birth outcome in consecutive pregnancies, first time 
mothers were ineligible for study participation. Eligible participants 
were second and third time mothers of Caucasian origin who spoke 
one of the Scandinavian languages, had a singleton pregnancy, and 
were registered by the study center prior to the 20th gestational week. 
In total, we recruited 5,722 women, from which we defined three 
groups: a 10% random sample representative of the parous popula-
tion at each study site (n = 561); a group at high risk for SGA birth (n 
= 1,384), and a low risk group (n = 3,777) (Figure 3). Both the ran-
dom sample and high-risk group were included for detailed follow-up 
throughout pregnancy and at birth. The high risk group was defined 
by one or more of the following risk factors: (i) a prior SGA or low-
birth-weight (LBW) child, (ii) maternal cigarette smoking at concep-
tion, (iii) low prepregnancy weight (<50 kg), (iiii) a previous perinatal 
death, or (iiiii) the presence of chronic maternal disease including 
essential hypertension or renal disease. In the current study, we used 
a case–cohort design (33) to estimate the associations between prena-
tal EDC exposure and indices of fetal growth. In total, 143 SGA births 
were selected as cases, and 281 non-SGA controls were selected from 
the 10% random sample group (total n = 424) (Figure 3). Selection 
was based on the availability of second trimester maternal serum 
samples.
Exposure Assessment
Serum samples were collected in second trimester (gestational week 
17–20) in the SGA study (1986–1988) and serum was stored at −80 
°C for later analysis. All 424 samples were included for PFAS and OC 
analyses. All chemicals presented were detected in 100% of the sam-
ples, except β-hexachlorohexane (β-HCH) that was detected in 99%. 
Limits of detection (LODs) are listed in Table 2, and values below 
LOD were replaced by LOD/√2.
Chemical Analyses of PFAS
Analyses were performed at the laboratories of Norwegian Institute 
for Air Research, Tromsø, Norway (NILU). All serum samples were 
Figure 3. Flow chart of the study selection. aNumber of participants from the 10% random sample. bNumber of participants from the high-risk group.
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quantified for two target analytes; perfluorooctanoate (PFOA) and 
PFOS. They were analyzed using sonication-facilitated liquid-liquid 
extraction, activated ENVI-carb clean-up (34), quantified and ana-
lyzed by ultrahigh pressure liquid chromatography triple-quadruple 
mass-spectrometry (UHPLC-MS/MS). Sample preparation and 
extraction were performed as described by Hanssen et al (35) except 
for minor volume changes. The quantification was conducted with the 
LC Quan software, version 2.6.0 (Thermo Fisher Scientific, Waltham, 
MA). The internal-standard addition method with isotope-labeled 
PFASs was used to quantify the contaminants (35). Participation in 
the AMAP Ring Test (36) indicates that the uncertainties of the analy-
sis are within ± 15–20% of the assigned values.
Chemical Analyses of OCs
OCs were analyzed at the Institut National de Santé Publique du 
Quebec, Centre Toxicologie, Quebec. This laboratory is the organizer 
of the AMAP Ring Test (36). OCs measured were hexachloroben-
zene (HCB), oxychlordane, polychlorinated biphenyl (PCB) 52, 101, 
118, 153, 156, 170, and 180, p,p’-dichlorodiphenyldichloroehylene 
(p,p’-DDE), p,p’-dichlorophenyltrichloroethane (p,p’-DDT), β-
hexachlorohexane (β-HCH) and trans-nonachlor (t-NC). We chose 
to report PCB 153 representing total PCBs, and excluded p,p-DDT 
because of low detection limit (>50% of samples <LOD). In short, 
0.5–1 ml serum sample was extracted using hexane (2 × 6 ml), etha-
nol (2 ml) and saturated ammonium sulphate solution (2 ml), a slight 
modification of Sandanger et al. (37).
Outcome Assessment
Indices of fetal growth including birth weight (continuous; grams 
(g)), birth length (continuous; centimeters (cm)) and head circum-
ference (continuous; cm) were measured and recorded at birth. 
Gestational age (continuous; completed weeks) was determined by 
ultrasound scan at 17 wk of gestation. SGA birth was defined as birth 
weight below the 10th percentile adjusted for gestational age, parity 
and sex of child (32).
Covariates
Based on prior knowledge of PFAS and OC properties, and known 
risk factors for SGA birth, we included potential confounders from 
data collected at first study visit in gestational week 17. These involved 
maternal age (continuous; years), maternal height (continuous; cm), 
maternal prepregnancy BMI (continuous; kg/m2), education level 
(categorical; 9 y or less, 10–12 y, or 13 y or more), smoking status 
at conception (categorical; 0, 1–9 or >10 cigarettes per day), parity 
(binary; 1 or 2) and interpregnancy interval (categorical; 18 mo or 
less, 19–60 mo, 61 mo or more). We categorized the interpregnancy 
interval based on a known J-shaped association to adverse perinatal 
outcomes including restricted fetal growth (38). Offspring sex (male/
female) was registered at birth. Weight gain up to 17 wk was calcu-
lated based on recorded weight measurements done by midwives at 
the regular prenatal visits throughout pregnancy. Alcohol consump-
tion was self-reported in gestational week 33. Dietary information 
from the Norwegian women consisted of a self-reported food fre-
quency questionnaire over a 3-d period in week 17 and 33.
Statistical Analyses
PFAS and OC levels were logarithmically (ln) transformed to obtain 
normal distribution. We used wet weight concentrations of PFAS 
and lipid-adjusted serum concentrations of OCs (39). Total lipid 
values were calculated based on measurements of triglycerides and 
cholesterol:
Total lipids = 1.33*triglycerides + 1.12*cholesterol + 1.48 (g/l) 
(39). This formula showed good correlation with complete formulas 
including phospholipids (40).
In a complete case analysis we used uni- and multivariate lin-
ear regression with 95% confidence intervals (CIs) to estimate the 
adjusted associations between natural log-transformed (ln) serum lev-
els of seven individual EDCs (PFASs: PFOA, PFOS; OCs: PCB153, p,p’-
DDE, HCB, t-NC, and β-HCH) and indices of fetal growth including 
birth weight, birth length, head circumference and gestational age at 
birth. We evaluated linear model assumptions using diagnostic plots 
of the residuals. In all linear regression analyses we adjusted for the 
same covariates (maternal age, maternal height, prepregnancy BMI, 
maternal education level, smoking at conception, parity, interpreg-
nancy interval, and offspring sex). We conducted uni- and multivariate 
logistic regression to estimate the crude and adjusted odds ratios (ORs 
and aORs) for SGA birth per unit increase in natural log-transformed 
(ln) serum levels of each PFAS and OC. In all the logistic regression 
analyses we adjusted for the same covariates (maternal age, mater-
nal height, prepregnancy BMI, maternal education level, smoking at 
conception, and interpregnancy interval). SGA birth was defined as 
birthweight below the 10th percentile adjusted for gestational age, par-
ity and offspring sex; hence, we did not adjust for parity or offspring 
sex in the models with SGA birth as an outcome. Based on the evi-
dence of effect modification by geography, we stratified our results by 
country of residence. In multivariate logistic models with SGA as out-
come variable, we found significant P values for interaction between 
the different EDCs and country of residence (PFOA P = 0.043; PCB 
153 P = 0.073; HCB P = 0.008). In multivariate linear regression mod-
els with birth weight as an outcome, P values for the interaction term 
were 0.004, 0.001, and 0.036 for PFOA, PFOS, and HCB, respectively. 
Within country-specific strata, we further considered possible effect 
modification by offspring sex, because proposed endocrine disrupting 
properties might be sex-specific. Missing data was less than 10% for 
included covariates. All statistical analyses were conducted with SPSS 
statistical software, version 22 (IBM SPSS, Chicago, IL).
SUPPLEMENTARY MATERIAL
Supplementary material is linked to the online version of the paper at http://
www.nature.com/pr
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